跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PRECEDEX dexmedetomidine hydrochloride 200 micrograms/2mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PRECEDEX dexmedetomidine hydrochloride 200 micrograms/2mL injection vial
Approved
STANDARD
PRECEDEX dexmedetomidine hydrochloride 200 micrograms/2mL injection vial
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
cd4b600a49cbe16b
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
cd4b600a49cbe16b
Product Name
PRECEDEX dexmedetomidine hydrochloride 200 micrograms/2mL injection vial
Artg Id
81323
Artg Name
PRECEDEX dexmedetomidine hydrochloride 200 micrograms/2mL injection vial
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2002-04-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/057900e170b355492b8a861323536a95.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/c8a5d1ca5cf34266ddc256df73851673.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
cd4b600a49cbe16b
Type
Standard
Back to TGA Approvals